Results 31 to 40 of about 29,053 (244)
World Journal of Nuclear Medicine, 2020 In recent years, lutetium-177 (177Lu)-labeled prostate-specific membrane antigen (PSMA)-617 has become a promising new therapeutic agent in patients with metastatic castration-resistant prostate cancer (mCRPC).
Majid Assadi +9 more
doaj +1 more source
Combination Therapies with PRRT
Pharmaceuticals, 2021 Peptide receptor radionuclide therapy (PRRT) is a successful targeted radionuclide therapy in neuroendocrine tumors (NETs). However, complete responses remain elusive.
Anna Yordanova, Hojjat Ahmadzadehfar
doaj +1 more source
Frontiers in Physics, 2021 Nuclear data are important for production and medical application of a radionuclide. This brief review concentrates on nuclear reaction cross-section data.
Syed M. Qaim +3 more
doaj +1 more source
RetroSPECT: Gallium-67 as a Long-Lived Imaging Agent for Theranostics [PDF]
Asia Oceania Journal of Nuclear Medicine and Biology, 2021 A limitation to the wider introduction of personalised dosimetry in theranostics is the relative paucity of imaging radionuclides with suitable physical and chemical properties to be paired with a long-lived therapeutic partner.
Dale Bailey +5 more
doaj +1 more source
Radiolabeled nanomaterial for cancer diagnostics and therapeutics: principles and concepts
Cancer Nanotechnology, 2023 In the last three decades, radiopharmaceuticals have proven their effectiveness for cancer diagnosis and therapy. In parallel, the advances in nanotechnology have fueled a plethora of applications in biology and medicine.
Muskan Goel +2 more
doaj +1 more source
PEPTIDE BASED TARGETED RADIONUCLIDE THERAPIES; SCIENCE BEHIND THE SUCCESS.
Journal of Cancer and Allied Specialties, 2016 The radionuclide therapies for solid and liquid malignancies are emerging field nowadays. The targeted radionuclide therapies have been in use since 1945.
Mohammed H Al Rowaily +4 more
doaj +1 more source
USE OF 177Lu-PSMA FOR RADIONUCLIDE THERAPY IN PATIENTS WITH CASTRATE-RESISTANT PROSTATE CANCER
Сибирский онкологический журнал, 2021 Purpose of the study: to present current data regarding challenges in treatment of castration-resistant prostate cancer (CRPC) and the relationship between CRPC and the expression of prostate-specific membrane antigen (psma).Material and Methods.
A. A. Medvedeva +5 more
doaj +1 more source
Nuclear medicine and molecular imaging in clinical practice: yesterday, today and tomorrow
Терапевтический архив, 2021 Over the past 40 years, nuclear medicine has grown to be the largest non-invasive diagnostic and therapeutic industry in the world, playing a pivotal role in various fields and disciplines of clinical practice and contributing to improved quality of life
Vladimir B. Sergienko +1 more
doaj +1 more source
Metal Nanoclusters for Cancer Imaging and Treatment
Advanced Functional Materials, EarlyView.This review aims to provide a comprehensive summary and discussion of the core–shell design capabilities of metal nanoclusters (NCs) at the atomic level for cancer imaging and treatment. It offers essential insights into the design principles of metal NCs while also encouraging the exploration of other nanomaterials and their potential theranostic ...
Haiguang Zhu +5 more
wiley +1 more source
Frontiers in Chemistry, 2023 Copper has several clinically relevant radioisotopes and versatile coordination chemistry, allowing attachment of its radionuclides to biological molecules.
Mazhar Hussain +5 more
doaj +1 more source